Know Cancer

or
forgot password


Phase 2/Phase 3
18 Years
85 Years
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information


Inclusion Criteria:



- Colorectal cancer participants were identified by colonoscopy to have at least one
historically confirmed colorectal cancer.

Exclusion Criteria:

- Age<18 years

- Pregnant women

- Had a history of colorectal cancer

- Attenuated adenomatous polyposis coli

- Inflammatory bowel disease or were taking any medication which could influence
homocysteine, folate, vitamin B6 and B12 status, such as H2 blockers, Proton pump
inhibitors, metformin, phenytoin, methotrexates.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention

Outcome Measure:

Antioxidant and DNA methylation

Outcome Description:

This study are going to measure the oxidative stress (TBARs), antioxidant activities and DNA methylation in colorectal cancer patients

Outcome Time Frame:

12 months

Safety Issue:

No

Authority:

Taiwan: Department of Health

Study ID:

S10251

NCT ID:

NCT01426490

Start Date:

August 2011

Completion Date:

July 2015

Related Keywords:

  • Colorectal Cancer
  • Colorectal Neoplasms

Name

Location